source
- Vertex posts strong Q2 earnings, but upcoming Sionna cystic fibrosis data casts a shadowVertex reported Q2 revenue from its cystic fibrosis portfolio exceeding $3.2 billion, beating estimates and prompting an upward revision of full‑year revenue guidance to $13.1‑$13.2 billion. Analy…
- Pathos AI signs two cancer deals, including $2 bn contract with China's Alphamab and partnership with AstraZenecaPathos AI announced two new collaborations to expand its oncology pipeline, one with AstraZeneca and another with a subsidiary of China's Alphamab Oncology. The deal with Jiangsu Alphamab Biopharm…